PB2301: OPTIMAL DOSE INTENSITY OF R-CHOP FOR PATIENTS WITH DLBCL AGED 80 YEARS OR OLDER: IS THE R-MINICHOP A GOLD STANDARD?

• Hironao Nukariya,
• Katsuhiro Miura,
• Hiromichi Takahashi,
• Masaru Nakagawa,
• Takashi Hamada,
• Shun Ito,
• Takashi Ichinohe,
• Endo Toshihide,
• Kazuya Kurhihara,
• Takashi Koike,
• Kazuhide Iizuka,
• Shimon Ohtake,
• Noriyoshi Iriyama,
• Yoshihiro Hatta,
• Hideki Nakamura

Affiliations

Hironao Nukariya

1 Nihon University School of Medicine, Hematology and Rheumatology, Tokyo, Japan

Katsuhiro Miura

1 Nihon University School of Medicine, Hematology and Rheumatology, Tokyo, Japan

Hiromichi Takahashi

1 Nihon University School of Medicine, Hematology and Rheumatology, Tokyo, Japan

Masaru Nakagawa

1 Nihon University School of Medicine, Hematology and Rheumatology, Tokyo, Japan

Takashi Hamada

1 Nihon University School of Medicine, Hematology and Rheumatology, Tokyo, Japan

Shun Ito

1 Nihon University School of Medicine, Hematology and Rheumatology, Tokyo, Japan

Takashi Ichinohe

1 Nihon University School of Medicine, Hematology and Rheumatology, Tokyo, Japan

Endo Toshihide

1 Nihon University School of Medicine, Hematology and Rheumatology, Tokyo, Japan

Kazuya Kurhihara

1 Nihon University School of Medicine, Hematology and Rheumatology, Tokyo, Japan

Takashi Koike

1 Nihon University School of Medicine, Hematology and Rheumatology, Tokyo, Japan

Kazuhide Iizuka

1 Nihon University School of Medicine, Hematology and Rheumatology, Tokyo, Japan

Shimon Ohtake

1 Nihon University School of Medicine, Hematology and Rheumatology, Tokyo, Japan

Noriyoshi Iriyama

1 Nihon University School of Medicine, Hematology and Rheumatology, Tokyo, Japan

Yoshihiro Hatta

1 Nihon University School of Medicine, Hematology and Rheumatology, Tokyo, Japan

Hideki Nakamura

1 Nihon University School of Medicine, Hematology and Rheumatology, Tokyo, Japan